SpyGlass Pharma, Inc (SGP) Stock Price Today & Analysis
Valuation
Earnings Per Share
Income Statement
Dividend
Solvency
About SpyGlass Pharma, Inc
The company is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company seeks to improve patient outcomes by developing durable drug delivery solutions that support long-term disease control and vision preservation, providing confidence for both patients and surgeons. Its lead product candidate, the Bimatoprost Drug Pad–Intraocular Lens System (BIM-IOL System), consists of novel, proprietary drug pads attached to an intraocular lens (IOL) and is designed for implantation during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
FAQ
- Download the Gotrade app from the App Store or Google Play.
- Create an account and complete KYC.
- Make a deposit.
- Search for the code "SGP", then tap "Trade".
- Tap the "Buy" button.
- Enter the amount you want to buy. You have two options:
- Buy SGP by number of shares.
- Buy fractional shares in dollars, starting from $1.
- Swipe up to confirm your order—done!
- Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
- Review revenue and earnings growth.
- Check margins and cash flow.
- Evaluate business outlook and the company's position within its industry.





